TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Alexion Pharma Nordics AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
24,272
|
23,504
|
22,897 |
Financial expenses |
162
|
4
|
17 |
Earnings before taxes |
1,123
|
700
|
953 |
EBITDA |
1,111
|
654
|
970 |
Total assets |
15,909
|
9,673
|
9,023 |
Current assets |
15,909
|
9,673
|
9,008 |
Current liabilities |
10,985
|
5,546
|
5,175 |
Equity capital |
4,923
|
4,126
|
3,847 |
- share capital |
5
|
4
|
5 |
Employees (average) |
14
|
15
|
16 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
30.9%
|
42.7%
|
42.6% |
Turnover per employee |
1,734
|
1,567
|
1,431 |
Profit as a percentage of turnover |
4.6%
|
3.0%
|
4.2% |
Return on assets (ROA) |
8.1%
|
7.3%
|
10.8% |
Current ratio |
144.8%
|
174.4%
|
174.1% |
Return on equity (ROE) |
22.8%
|
17.0%
|
24.8% |
Change turnover |
700
|
2,462
|
549 |
Change turnover % |
3%
|
12%
|
2% |
Chg. No. of employees |
-1
![]() |
-1
|
5 |
Chg. No. of employees % |
-7%
|
-6%
|
45% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.